Pristinamycin
Top View
- Executive Summary
- 6-Veterinary-Medicinal-Products-Criteria-Designation-Antimicrobials-Be-Reserved-Treatment
- Protein Synthesis Inhibitors
- Forgotten Antibiotics: an Inventory in Europe, the United States, Canada, and Australia
- Correction of Linezolid-Induced Myelotoxicity After Switch To
- Prosthetic Jointinfection Treatmentguidance
- EARS-Net (European Antimicrobial Resistance Surveillance Network
- Recommendations for Anti-Microbial Use for Secondary Infections in Patients with COVID-19 Rapid Review
- Antibiotic Resistance Gene Resource and Assay List
- Antibiotic Discovery: History, Methods and Perspectives
- EAU Guidelines on Urological Infections 2020
- The Prevalence of Ureaplasma Urealyticum and Mycoplasma Hominis Infections in Infertile Patients in the Northeast Region of Romania
- Literature Search Strategy for Treatment of Stable
- Antibiotics That Inhibit 30S Or 50S Ribosomal Subunit Formation: Hygromycin B, Quinupristin- Dalfopristin and XRP 2868
- Antibiotics of the Virginiiamycin Family, Inhibitors Which Contain Synergistic Components C
- Supplementary Material Biosynthetic Pathways for Relevant
- In-Host Emergence of Linezolid Resistance in a Complex Pattern Of
- ICD-10-CM TABLE of DRUGS and CHEMICALS 2020